|« Previous month||Next month »|
31-Jul-2012 - Catalent has replaced all stainless steel bioreactors at its biologics facility in Middleton, Wisconsin with single-use techs citing cost and flexibility advantages.
31-Jul-2012 - US Preclinical CRO Ricerca has launched two new assay services one of which is designed to help assess the risk a biologic drug will induce a cytokine storm.
31-Jul-2012 - BioFocus and Activiomics have teamed up to offer a drug discovery and biomarker service which it says will improve the identification of novel targets.
30-Jul-2012 - Developments in the CRO sector continue despite the summer vacation season with news from GVK Biosciences and ClinTec International.
30-Jul-2012 - Spanish pharmaceutical firm Almirall has called on Quintiles to help promote its respiratory drug portfolio in the UK.
30-Jul-2012 - Outcome-based payment for CRO services is the “wave of the future” for pharmaceutical outsourcing, according to iGate.
26-Jul-2012 - Covance has reported a net loss of $12.7m in this year’s Q2 as what it says is the result of facility closures and restructuring costs, particularly for its early phase...
26-Jul-2012 - The US Patient-Centered Outcomes Research Institute (PCORI) has suggested the pharmaceutical industry is introducing bias into clinical trials through selective use of inclusion/exclusion criteria and comparators.
25-Jul-2012 - Beta Pharma Canada will produce a batch of adva-27a, a developmental cancer drug being developed by Sunshine Biopharma.
25-Jul-2012 - The global CMO market will grow from $26bn in 2010 to $59.9bn by 2018 thanks to a boom in the amount of work outsourced to the Asia market, says GBI Research.
24-Jul-2012 - Parexel says EU trials directive never achieved harmonization aims and welcomes plans to simplify regulations, even if the implementation date is further away than expected.
24-Jul-2012 - Novasep has joined the growing number of manufacturers betting on the antibody drug conjugate (ADC) market with a €3m investment at its plant in Le Mans, France.
24-Jul-2012 - Icon’s operating profits have dropped by almost half since last year as a result of a $5.6m payout related to restructuring costs.
23-Jul-2012 - SPIC has pressed the Indian PM to issue a standardised excise duty to all contract manufacturers operating in the country so drugsmakers can have a level playing field.
23-Jul-2012 - The billion dollar Korea Drug Development Fund (KDDF) has called on US CRO Parexel to help local developers commercialise pharmaceuticals on the global market.
23-Jul-2012 - Reports suggest Covance has sold its minority stake in biomarker service firm Caprion Proteomics which has been acquired by Chicago Growth Partners.
23-Jul-2012 - Outsourcing-Pharma.com presents its weekly low down of the movers and shakers in the world of pharmaceuticals, including news from Parexel, Ricerca, and CSC.
19-Jul-2012 - The EC says proposals to replace the Clinical Trials Directive with simplified rules will make Europe more attractive for trials, but what do CROs think? Share your opinions in this...
19-Jul-2012 - Approval of Qsymia - Vivus’ anti-obesity drug – may be good news for the 35 per cent of US citizens classed as obese , but it is definitely good news for...
18-Jul-2012 - European lawmakers still need to decide how to inspect clinical trials in non-EU countries under proposed regulatory reforms adopted by the EC.
18-Jul-2012 - Outsourcing-Pharma.com presents the latest in the busy world of pharmaceutical careers, including news from PPD, Parallon, ShangPharma and C3i.
18-Jul-2012 - API production in India will take a hit this week with plant closures for Aurobindo, Hetero Drugs, Divis Pharmaceuticals, and Sri Krishna Pharmaceuticals following allegations of environmental wrongdoing.
17-Jul-2012 - BioFocus has taken on Titian’s sample management software in a bid to pump more resources into “refreshing” its 900,000 strong high-throughput screening (HTS) compound portfolio.
17-Jul-2012 - DSM Pharmaceutical Products (DPP) has won its second biologics manufacturing contract in two months signing up Brazil’s Recepta Biopharma as a new customer.
17-Jul-2012 - Ohio, US-based CRO Medpace says it has finished work on a new pharmacology unit in Cincinnati and plans to close its old facility in Norwood.
17-Jul-2012 - The CEO of Medidata has said big eClinical mergers can succeed if there is an alignment of the businesses and technologies.
16-Jul-2012 - The location of a clinical trial has no-impact on data quality according to new research.
16-Jul-2012 - LabCorp moves closer to expanding central labs biz, Quintiles builds in Brazil, Synexus grows in South Africa and CRI opens new research facility - Welcome to Outsourcing-pharma.com’s round up of...
12-Jul-2012 - Ampac gets the OK from the DEA, Syngene lands PE-ED manufacturing contract and Great Southern is bought by Pernix Therapeutics – welcome to Outsourcing-pharma.com’s CMO round-up.
12-Jul-2012 - Dishman Pharmaceuticals has abandoned plans to set up a special economic zone (SEZ) citing law changes that make the project less attractive and unfavourable economics as the reasons for the decision. ...
12-Jul-2012 - inVentiv Health’s medical management business – iMM – has partnered with patient behavioural counselling firm Vital Decisions to develop a care management and counselling programme for patients suffering from progressive disorders.
12-Jul-2012 - Outsourcing-Pharma.com presents its latest round-up of the latest newcomers and career climbers in the world of pharmaceuticals, including news from AMRI, Ark, and IMC.
11-Jul-2012 - Specialist aerosol CDMO Exemplar Pharma has been issued with a 483 by the US FDA for inadequate process control procedures.
11-Jul-2012 - Leading eClinical firms will win market share over the next decade as biopharma firms stick with tools they know, an analyst predicts.
10-Jul-2012 - CROs can expect more business from medical device makers as regulations become more complex according to Pacific Biolabs.
10-Jul-2012 - Lab services firm Warnex has rejigged its finances yet again and reiterated its plans to focus on the contract bioanalytical testing market.
09-Jul-2012 - No job losses, facility divestitures or strategic changes are planned at DPT Laboratories according to new owner Renaissance Pharma, which bought the CDMO in an out-of-the-blue deal last week.
09-Jul-2012 - eResearch Technologies (ERT) says it will buy invivodata citing the electronic patient reported outcomes (ePRO) market as the key driver for the deal.
09-Jul-2012 - iGATE says its new information management platform will provide a 70 per cent decrease in content management costs for the drug development process.
05-Jul-2012 - RSSL says its new foreign body inspection team could help get offline factories up and running more quickly following incidents of contamination.
05-Jul-2012 - The EMA wants a debate on the extrapolation of clinical data to see if a framework is needed to govern this potential approach to reducing unnecessary research and letting industry...
05-Jul-2012 - ‘Merge CDMO and CRO activities to fix the holes in the early phase clinical research industry’, said Quotient Clinical’s CEO Mark Egerton.
04-Jul-2012 - Argentina’s clinical trial market will hit $76m (EUR60.4) by 2015 with growth driven by low costs, a good regulatory environment and large patient populations, according to a new study.
04-Jul-2012 - The US NIH has clarified its position on research animal welfare after its original statement raises concerns.
04-Jul-2012 - Outsourcing-Pharma.com presents its weekly round-up of the changing faces in the world of pharmaceuticals, including news from Icon, NIH and Theradiag.
03-Jul-2012 - Cutting in-house R&D staff to outsource more activities cuts will drive the industry forward, according to a new report.
03-Jul-2012 - Outsourcing-Pharma.com presents a round-up of the latest contract manufacturing investments, including new screening services for Imaxio, Encap’s renewed push for its CMO biz, and Pernix’s bid to take over Great...
03-Jul-2012 - European laws on clinical trials need to be faster and more efficient but they are not the only reason for the decline in the sector according to EU health and...
02-Jul-2012 - A new draft guidance stating the level of insurance cover required for trial participants in the UK will accelerate ethics committees’ approval process, according to experts.
02-Jul-2012 - API maker ScinoPharm is to invest in cancer drug and injectables capacity, citing current global shortages as a driver for its decision.
02-Jul-2012 - Emeryville Pharmaceutical Services (EPS) has launched a new “same day” chemistry and microbiology analysis service.
02-Jul-2012 - A quarter of procedures carried out during clinical trials may be pointless according to a new study, which suggests that this unnecessary work costs around $5bn (€3.96bn) a year. ...
|« Previous month||Next month »|